Clinical Trial: Evaluation of Butyrate and Palmitoylethanolamide in IBS Patients (B/P3_1)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Irritable Bowel Syndrome With Diarrhea
Study Type: INTERVENTIONAL
Official Title: Evaluation of Butyrate and Palmitoylethanolamide Effects on Intestinal Permeability and Microbiota Gut Composition in Patients With Irritable Bowel Syndrome - A Double-blind, Placebo-controlled Crosso
Brief Summary:
Evaluation of the effects of butyrate ( BitirBioma) and palmitoylethanolamide( PEA=PeaBioma) on intestinal permeability and gut microbiota composition in patients with irritable bowel syndrome.Study B/P 3_1 is an interventional study involving the use of food supplements on the market (BitirBioma Plus and PeaBioma Plus), single-center, double-blind, placebo-controlled, crossover, randomized, in n=50 patients with bowel syndrome irritable, diarrheal and mixed variant (IBS-D and IBS-M), lasting for one year.The…
Read more